These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 19902664
1. Antiarrhythmic and cardioprotective effects of remifentanil in anesthetized dogs. Luna-Ortiz P, Zarco-Olvera G, Ramírez-Ortega M, Tenorio-López FA, Gutiérrez A, Martínez-Rosas M, Del-Valle Mondragón L, Pastelín G. Arch Cardiol Mex; 2009; 79(3):182-8. PubMed ID: 19902664 [Abstract] [Full Text] [Related]
2. [Early and late effects of adenosine in experimental ventricular tachycardia]. de Micheli A, Chávez Domínguez R, Iturralde Torres P, Pastelín G, Medrano GA. Rev Esp Cardiol; 2005 Feb; 58(2):159-66. PubMed ID: 15743562 [Abstract] [Full Text] [Related]
3. Differential effect of some antiarrhythmic drugs in right- or left-sided aconitine-induced experimental atrial arrhythmias. Gautam CS, Lal R, Pandhi P, Sharma PL. Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):91-3. PubMed ID: 3586773 [Abstract] [Full Text] [Related]
4. Antiarrhythmic and arrhythmogenic action of inosine in experimental ventricular tachyarrhythmias. de Micheli A, Pastelín G, Chávez Domínguez R, Iturralde Torres P, Medrano GA. Arch Cardiol Mex; 2009 Feb; 79(3):175-81. PubMed ID: 19902663 [Abstract] [Full Text] [Related]
5. Antiarrhythmic properties of MJ 9067 in acute animal models. Byrne JE, Gomoll AW, McKinney GR. J Pharmacol Exp Ther; 1977 Jan; 200(1):147-54. PubMed ID: 401883 [Abstract] [Full Text] [Related]
6. Differential efficacy of the class III agent MK-499 against programmed stimulation-induced and ischemic-induced ventricular arrhythmias in a canine model of previous myocardial infarction. Lynch JJ, Wallace AA, Stump GL, Stupienski RF, Kothstein T, Gehret JR. J Pharmacol Exp Ther; 1996 May; 277(2):671-8. PubMed ID: 8627544 [Abstract] [Full Text] [Related]
7. Digoxin-induced toxicity and experimental atrioventricular block in dogs. Relation between ventricular arrhythmias and oscillatory afterpotentials. Adamantidis MM, Duriez PR, Vincent AC, Dupuis BA. J Pharmacol; 1983 May; 14(3):333-49. PubMed ID: 6632915 [Abstract] [Full Text] [Related]
9. Effects of flecainide on atrial and ventricular stimulation thresholds to repetitive extrasystoles and fibrillation and on "2nd Phase" ventricular arrhythmias in dogs. Heuer H, Gülker H, Thale J, Bender F. Arzneimittelforschung; 1983 May; 33(12):1651-4. PubMed ID: 6199033 [Abstract] [Full Text] [Related]
10. Cardioprotective action of fentanyl in a model of central sympathetic overactivity in rabbits: antiarrhythmic and anti-ischemic effects. Lessa MA, Rodrigues E, Tibiricá E. Acta Anaesthesiol Scand; 2004 Oct; 48(9):1115-22. PubMed ID: 15352957 [Abstract] [Full Text] [Related]
17. Effects of apparently nontoxic doses of digoxin on ventricular ectopy after direct-current electrical shocks in dogs. Ditchey RV, Curtis GP. J Pharmacol Exp Ther; 1981 Jul; 218(1):212-6. PubMed ID: 7241379 [Abstract] [Full Text] [Related]
18. Effects of diltiazem on vulnerability to atrial and ventricular reentrant arrhythmias in the normal and ischemic heart. Heuer H, Gülker H, Thale J, Meyer M, Weiss U, Bendeer F. Arzneimittelforschung; 1983 Jul; 33(8):1113-6. PubMed ID: 6685488 [Abstract] [Full Text] [Related]
19. Model systems for the discovery and development of antiarrhythmic drugs. Nattel S, Duker G, Carlsson L. Prog Biophys Mol Biol; 2008 Jul; 98(2-3):328-39. PubMed ID: 19038282 [Abstract] [Full Text] [Related]